421 related articles for article (PubMed ID: 20559016)
21. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa.
Shirasaki H; Kikuchi M; Kanaizumi E; Himi T
Ann Allergy Asthma Immunol; 2009 Feb; 102(2):110-5. PubMed ID: 19230460
[TBL] [Abstract][Full Text] [Related]
23. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2.
Yamamoto M; Okano M; Fujiwara T; Kariya S; Higaki T; Nagatsuka H; Tsujigiwa H; Yamada M; Yoshino T; Urade Y; Nishizaki K
Int Arch Allergy Immunol; 2009; 148(2):127-36. PubMed ID: 18802357
[TBL] [Abstract][Full Text] [Related]
24. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.
Gervais FG; Cruz RP; Chateauneuf A; Gale S; Sawyer N; Nantel F; Metters KM; O'neill GP
J Allergy Clin Immunol; 2001 Dec; 108(6):982-8. PubMed ID: 11742277
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
Gervais FG; Sawyer N; Stocco R; Hamel M; Krawczyk C; Sillaots S; Denis D; Wong E; Wang Z; Gallant M; Abraham WM; Slipetz D; Crackower MA; O'Neill GP
Mol Pharmacol; 2011 Jan; 79(1):69-76. PubMed ID: 20943773
[TBL] [Abstract][Full Text] [Related]
26. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R
Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
[TBL] [Abstract][Full Text] [Related]
28. Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation.
Ulven T; Kostenis E
Curr Top Med Chem; 2006; 6(13):1427-44. PubMed ID: 16918458
[TBL] [Abstract][Full Text] [Related]
29. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.
Nagata K; Hirai H
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):169-77. PubMed ID: 12895600
[TBL] [Abstract][Full Text] [Related]
30. Effects of prostaglandin D2 on helper T cell functions.
Tanaka K; Hirai H; Takano S; Nakamura M; Nagata K
Biochem Biophys Res Commun; 2004 Apr; 316(4):1009-14. PubMed ID: 15044085
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).
Tasaki M; Kobayashi M; Tenda Y; Tsujimoto S; Nakazato S; Numazaki M; Hirano Y; Matsuda H; Terasaka T; Miyao Y; Shimizu Y; Hirayama Y
Eur J Pharm Sci; 2013 Jun; 49(3):434-40. PubMed ID: 23624353
[TBL] [Abstract][Full Text] [Related]
32. Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.
Ulven T; Receveur JM; Grimstrup M; Rist Ø; Frimurer TM; Gerlach LO; Mathiesen JM; Kostenis E; Uller L; Högberg T
J Med Chem; 2006 Nov; 49(23):6638-41. PubMed ID: 17154491
[TBL] [Abstract][Full Text] [Related]
33. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
[TBL] [Abstract][Full Text] [Related]
34. Expression and molecular pharmacology of the mouse CRTH2 receptor.
Hata AN; Zent R; Breyer MD; Breyer RM
J Pharmacol Exp Ther; 2003 Aug; 306(2):463-70. PubMed ID: 12721327
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles of prostaglandin D2 receptors in chronic skin inflammation.
Matsushima Y; Satoh T; Yamamoto Y; Nakamura M; Yokozeki H
Mol Immunol; 2011 Oct; 49(1-2):304-10. PubMed ID: 21943706
[TBL] [Abstract][Full Text] [Related]
36. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases.
Pettipher R; Hansel TT; Armer R
Nat Rev Drug Discov; 2007 Apr; 6(4):313-25. PubMed ID: 17396136
[TBL] [Abstract][Full Text] [Related]
37. [Prostaglandin D2 in allergy: PGD2 has dual receptor systems].
Hirai H
Nihon Yakurigaku Zasshi; 2004 Jan; 123(1):15-22. PubMed ID: 14695454
[TBL] [Abstract][Full Text] [Related]
38. Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2).
Boehme SA; Franz-Bacon K; Chen EP; Ly TW; Kawakami Y; Bacon KB
Int Immunol; 2009 Jun; 21(6):621-32. PubMed ID: 19346259
[TBL] [Abstract][Full Text] [Related]
39. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
Hata AN; Lybrand TP; Marnett LJ; Breyer RM
Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.
Shiraishi Y; Asano K; Nakajima T; Oguma T; Suzuki Y; Shiomi T; Sayama K; Niimi K; Wakaki M; Kagyo J; Ikeda E; Hirai H; Yamaguchi K; Ishizaka A
J Pharmacol Exp Ther; 2005 Mar; 312(3):954-60. PubMed ID: 15528449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
